PPARs modulate cardiac metabolism and mitochondrial function in diabetes


Diabetic cardiomyopathy is a major complication of diabetes mellitus (DM). Currently, effective treatments for diabetic cardiomyopathy are limited. The pathophysiology of diabetic cardiomyopathy is complex, whereas mitochondrial dysfunction plays a vital role in the genesis of diabetic cardiomyopathy. Metabolic regulation targeting mitochondrial dysfunction is expected to be a reasonable strategy for treating diabetic cardiomyopathy. Peroxisome proliferator-activated receptors (PPARs) are master executors in regulating glucose and lipid homeostasis and also modulate mitochondrial function. However, synthetic PPAR agonists used for treating hyperlipidemia and DM have shown controversial effects on cardiovascular regulation. This article reviews our updated understanding of the beneficial and detrimental effects of PPARs on mitochondria in diabetic hearts.

DOI: 10.1186/s12929-016-0309-5

4 Figures and Tables


Citations per Year

202 Citations

Semantic Scholar estimates that this publication has 202 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Lee2016PPARsMC, title={PPARs modulate cardiac metabolism and mitochondrial function in diabetes}, author={Ting-Wei Lee and Kuan-Jen Bai and Ting-I Lee and Tze-fan Chao and Yu-Hsun Kao and Yi-Jen Chen}, booktitle={Journal of Biomedical Science}, year={2016} }